Bellecave Pantxika, Gouttenoire Jérôme, Gajer Markus, Brass Volker, Koutsoudakis George, Blum Hubert E, Bartenschlager Ralf, Nassal Michael, Moradpour Darius
Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
Hepatology. 2009 Jul;50(1):46-55. doi: 10.1002/hep.22951.
Coinfection with hepatitis B virus (HBV) and hepatitis C virus (HCV) has been associated with severe liver disease and frequent progression to cirrhosis and hepatocellular carcinoma. Clinical evidence suggests reciprocal replicative suppression of the two viruses, or viral interference. However, interactions between HBV and HCV have been difficult to study due to the lack of appropriate model systems. We have established a novel model system to investigate interactions between HBV and HCV. Stable Huh-7 cell lines inducibly replicating HBV were transfected with selectable HCV replicons or infected with cell culture-derived HCV. In this system, both viruses were found to replicate in the same cell without overt interference. Specific inhibition of one virus did not affect the replication and gene expression of the other. Furthermore, cells harboring replicating HBV could be infected with cell culture-derived HCV, arguing against superinfection exclusion. Finally, cells harboring replicating HBV supported efficient production of infectious HCV.
HBV and HCV can replicate in the same cell without evidence for direct interference in vitro. Therefore, the viral interference observed in coinfected patients is probably due to indirect mechanisms mediated by innate and/or adaptive host immune responses. These findings provide new insights into the pathogenesis of HBV-HCV coinfection and may contribute to its clinical management in the future.
乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)合并感染与严重肝脏疾病相关,且常进展为肝硬化和肝细胞癌。临床证据提示两种病毒相互复制抑制,即病毒干扰。然而,由于缺乏合适的模型系统,HBV与HCV之间的相互作用一直难以研究。我们建立了一种新型模型系统来研究HBV与HCV之间的相互作用。用可选择的HCV复制子转染可诱导复制HBV的稳定Huh-7细胞系,或用细胞培养来源的HCV感染该细胞系。在这个系统中,发现两种病毒可在同一细胞中复制而无明显干扰。对一种病毒的特异性抑制不影响另一种病毒的复制和基因表达。此外,携带复制性HBV的细胞可被细胞培养来源的HCV感染,这与超感染排斥不符。最后,携带复制性HBV的细胞支持传染性HCV的高效产生。
HBV和HCV可在同一细胞中复制,在体外无直接干扰的证据。因此,在合并感染患者中观察到的病毒干扰可能是由于先天性和/或适应性宿主免疫反应介导的间接机制。这些发现为HBV-HCV合并感染的发病机制提供了新的见解,并可能有助于未来对其进行临床管理。